Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001641172-25-001183
Filing Date
2025-03-28
Accepted
2025-03-28 16:05:36
Documents
75
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 2178147
2 ex4-4.htm EX-4.4 5144
3 ex23-1.htm EX-23.1 3648
4 ex31-1.htm EX-31.1 14183
5 ex31-2.htm EX-31.2 14696
6 ex32-1.htm EX-32.1 6841
7 ex32-2.htm EX-32.2 7295
8 form10-k_001.jpg GRAPHIC 13464
9 form10-k_002.jpg GRAPHIC 41282
10 audit_001.jpg GRAPHIC 32614
11 ex4-4_001.jpg GRAPHIC 544186
12 ex4-4_002.jpg GRAPHIC 456965
13 ex4-4_003.jpg GRAPHIC 937528
14 ex4-4_004.jpg GRAPHIC 311990
15 ex4-4_005.jpg GRAPHIC 827726
16 ex4-4_006.jpg GRAPHIC 736824
17 ex4-4_007.jpg GRAPHIC 402456
  Complete submission text file 0001641172-25-001183.txt   12806949

Data Files

Seq Description Document Type Size
18 XBRL SCHEMA FILE mira-20241231.xsd EX-101.SCH 36828
19 XBRL CALCULATION FILE mira-20241231_cal.xml EX-101.CAL 46194
20 XBRL DEFINITION FILE mira-20241231_def.xml EX-101.DEF 166049
21 XBRL LABEL FILE mira-20241231_lab.xml EX-101.LAB 377302
22 XBRL PRESENTATION FILE mira-20241231_pre.xml EX-101.PRE 296527
77 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 790181
Mailing Address 324 SOUTH HYDE PARK AVENUE, SUITE 350 TAMPA FL 33606
Business Address 1200 BRICKELL AVENUE SUITE 1950 #1183 MIAMI FL 33131 813-369-5150
MIRA PHARMACEUTICALS, INC. (Filer) CIK: 0001904286 (see all company filings)

EIN.: 853354547 | State of Incorp.: FL
Type: 10-K | Act: 34 | File No.: 001-41765 | Film No.: 25785934
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)